Mindy Goldsborough's Biography

Mindy Goldsborough, Chief Scientific Officer, ATCC

As the Chief Science and Technology Officer for ATCC, Mindy works across ATCC’s business units and functions to develop and implement the scientific and technology strategy in support of organizational goals. Additionally, she oversees the ATCC Cell Systems (ACS) business unit located within Maryland’s High Technology Corridor in Gaithersburg, MD. ACS is the innovative cell biology product and technology development arm of ATCC. Its current focus is in areas of functional cell biology supporting basic and translational research.

Prior to ATCC, Mindy was Director of R&D for BD Biosciences’ Advanced Bioprocessing group. Her previous work includes senior R&D roles at BD Biosciences’ Bioimaging business (formerly Atto Biosciences) and Life Technologies, where she led R&D efforts in DNA-based diagnostics, stem cell biology, forensics, and nucleic acid purification. Mindy has more than 25 years of product and technology development expertise in cell and molecular biology. Several products that she helped develop during her career are still market standards today.

Mindy earned her Ph.D. in Genetics from The George Washington University, and completed her dissertation research and post-doctoral work at The National Institutes of Health, National Cancer Institute.

Revolutionize Your Cancer Research With Next-Generation Models

Monday, 14 October 2019 at 17:30

Add to Calendar ▼2019-10-14 17:30:002019-10-14 18:30:00Europe/LondonRevolutionize Your Cancer Research With Next-Generation Models3D-Culture and Organoids 2019 in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com

While current in vitro models for cancer have been the backbone upon which decades of research and discovery have been built upon, there still exists a need within the research community for more advanced models. ATCC is tackling this challenge head-on. Through both internal R&D, as well as participation in consortia such as the Human Cancer Models Initiative, ATCC is delivering a wide variety of next-generation cancer models to the research community. These advanced models include CRISPR gene edited cell lines and 3D models annotated with clinical and genomic data to promote rapid scientific advancements toward understanding, treating, and curing cancer.

Add to Calendar ▼2019-10-14 00:00:002019-10-15 00:00:00Europe/London3D-Culture and Organoids 20193D-Culture and Organoids 2019 in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors